Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

FDA clears first inhaled corticosteroid for young children with asthma

Nov. 18, 1997

FDA clears new Tilade formulation

Nov. 18, 1997

Pharmacokinetic profile of ciclosporin derivative IMM-125

Nov. 18, 1997

FACET study demonstrates improved asthma control with Pulmicort and Oxis

Nov. 17, 1997

Novartis claims new antiasthmatic agents

Nov. 17, 1997

Pfizer describes new PDE IV inhibitor for asthma

Nov. 14, 1997

First interim phase III safety results reported for OxSODrol

Nov. 14, 1997

Pharmacokinetics, peripheral antihistaminic and central effects of rupatadine in humans

Nov. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026